The purpose of the study is to evaluate the effectiveness of use of the drug edaravone for treatment of patients with acute cerebral infarction comparing to citicoline. The results of the treatment of ischemic stroke by intravenous administration of edaravone (Xavron) and citicoline indicated a more pronounced elimination of neurological deficit in the group edaravone.

Authors: I.S. Cuckoo; A.O. Volosovets, A.I. Cuckoo and others

Posted: МЛ №1-2 (157-158) 2019